Article info

Download PDFPDF

Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer

Authors

  1. Correspondence to Dr Takayuki Yoshino; tyoshino{at}east.ncc.go.jp
View Full Text

Citation

Kotaka M, Yamanaka T, Yoshino T, et al
Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer

Publication history

  • Received March 9, 2018
  • Revised April 2, 2018
  • Accepted April 3, 2018
  • First published April 24, 2018.
Online issue publication 
April 24, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.